"This is obviously a disappointing outcome for A2 Milk in regards to short-term earnings potential or an opportunity to build brand awareness in the US," he says.
"It also creates uncertainty for Bubs who have secured temporary market access, in relation to prospects for more permanent market access beyond November, which is the end date of the policy.
"But he expects no changes to his forecasts since they don't assume any sales contribution under the FDA Formula Enforcement Discretion Policy.
$1 Party coming soon, page-97
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.4M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.0¢ | $90.66K | 685.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 3481808 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 817321 | 11 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BUB (ASX) Chart |